Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
2. Prt062070
1. 1198300-79-6
2. Cerdulatinib (prt062070)
3. Prt062070
4. Cerdulatinib [inn]
5. 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide
6. Prt-062070
7. D1lxq45s1o
8. Chembl4116008
9. Rvt-502
10. Prt-2070
11. Prt 062070
12. 4-(cyclopropylamino)-2-((4-(4-(ethanesulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
13. 5-pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)-
14. Prt2070
15. Unii-d1lxq45s1o
16. 4-(cyclopropylamino)-2-({4-[4-(ethanesulfonyl)piperazin-1-yl]phenyl}amino)pyrimidine-5-carboxamide
17. Cerdulatinib (prt2070)
18. Cerdulatinib [who-dd]
19. Schembl736734
20. Gtpl8957
21. Dtxsid001115521
22. Bcp10681
23. Ex-a2143
24. Yxb30079
25. Bdbm50468574
26. Nsc800071
27. Nsc825827
28. S3566
29. Akos026750510
30. Zinc114483165
31. Cs-3329
32. Db15499
33. Nsc-800071
34. Nsc-825827
35. Sb16931
36. Cerdulatinib; Prt062070; Prt2070
37. Ncgc00386415-04
38. 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide
39. Ac-30243
40. As-56368
41. Da-34986
42. Hy-15999
43. B8023
44. Ft-0741914
45. A14147
46. C71670
47. Q27075860
48. Prt2070; Prt-2070; Prt 2070; Prt-062070; Prt 062070; Prt062070
49. 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
| Molecular Weight | 445.5 g/mol |
|---|---|
| Molecular Formula | C20H27N7O3S |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 8 |
| Exact Mass | 445.18960892 g/mol |
| Monoisotopic Mass | 445.18960892 g/mol |
| Topological Polar Surface Area | 142 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 711 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
92
PharmaCompass offers a list of Cerdulatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cerdulatinib manufacturer or Cerdulatinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cerdulatinib manufacturer or Cerdulatinib supplier.
PharmaCompass also assists you with knowing the Cerdulatinib API Price utilized in the formulation of products. Cerdulatinib API Price is not always fixed or binding as the Cerdulatinib Price is obtained through a variety of data sources. The Cerdulatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cerdulatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cerdulatinib, including repackagers and relabelers. The FDA regulates Cerdulatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cerdulatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cerdulatinib supplier is an individual or a company that provides Cerdulatinib active pharmaceutical ingredient (API) or Cerdulatinib finished formulations upon request. The Cerdulatinib suppliers may include Cerdulatinib API manufacturers, exporters, distributors and traders.
Cerdulatinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cerdulatinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cerdulatinib GMP manufacturer or Cerdulatinib GMP API supplier for your needs.
A Cerdulatinib CoA (Certificate of Analysis) is a formal document that attests to Cerdulatinib's compliance with Cerdulatinib specifications and serves as a tool for batch-level quality control.
Cerdulatinib CoA mostly includes findings from lab analyses of a specific batch. For each Cerdulatinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cerdulatinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Cerdulatinib EP), Cerdulatinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cerdulatinib USP).